Skip to main content
SpringerLink
Log in

Obesity and inflammation: A new look at an old problem

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Obesity is a highly prevalent disease with multiple implications for cardiovascular morbidity and mortality. The traditional view of obesity is that excessive adipose tissue represents a passive storage depot of excess energy. However, obesity has been demonstrated to be a highly active endocrine organ with multiple metabolic pathways that interact with classic cardiac risk factors. The role of inflammation in atherosclerosis has been clarified by the ready availability of a variety of markers, including C-reactive protein, adiponectin, tumor necrosis factor-α, hemostatic markers, resistin, and a variety of emerging markers such as interleukins and adhesion molecules. Adipose tissue has been demonstrated to be the site of synthesis of a variety of proteins that are intimately involved in the regulation of inflammation. The concept that obesity represents an inflammatory state has gained credence over the past decade and has provided insights into the mechanisms of atherosclerosis and risk factor interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Mokdad AH, Ford ES, Bowman BA, et al.: The continuing increase of diabetes in the US. Diabetes Care 2001, 24:412.

    Article  PubMed  CAS  Google Scholar 

  2. Rashid MN, Fuentes F, Touchon RC, Wehner PS: Obesity and the risk for cardiovascular disease. Prev Cardiol 2003, 6:42–47.

    Article  PubMed  Google Scholar 

  3. Ogden CL, Carroll MD, Curtin LR, et al.: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295:1549–1555.

    Article  PubMed  CAS  Google Scholar 

  4. Hu FB, Willett WC, Li T, et al.: Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004, 351:2694–703.

    Article  PubMed  CAS  Google Scholar 

  5. Grundy SM, Cleeman JI, Daniels SR, et al.: American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735–2752.

    Article  PubMed  Google Scholar 

  6. Stern MP: Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 1995, 44:369–374.

    Article  PubMed  CAS  Google Scholar 

  7. Moshage HJ, Roelofs HM, van Pelt JF, et al.: The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988, 155:112–117.

    Article  PubMed  CAS  Google Scholar 

  8. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004, 44:6–11.

    Article  PubMed  CAS  Google Scholar 

  9. Devaraj S, Du Clos TW, Jialal I: Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 2005, 25:1359–1363.

    Article  PubMed  CAS  Google Scholar 

  10. Verma S, Devaraj S, Jialal I: Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006, 113:2135–2150; discussion 2150.

    PubMed  Google Scholar 

  11. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363–369.

    Article  PubMed  Google Scholar 

  12. Jialal I, Devaraj S: Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 2001, 116(Suppl):S108–S115.

    PubMed  Google Scholar 

  13. Muntner P, He J, Chen J, et al.: Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 2004, 14:686–695.

    Article  PubMed  Google Scholar 

  14. Clement K, Viguerie N, Poitou C, et al.: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004, 18:1657–1669.

    Article  PubMed  CAS  Google Scholar 

  15. Halaas JL, et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543–546.

    Article  PubMed  CAS  Google Scholar 

  16. Munzberg H, Flier JS, Bjorbaek C: Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004, 145:4880–4889.

    Article  PubMed  CAS  Google Scholar 

  17. Wannamethee SG, Tchernova J, Whincup P, et al.: Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2006, In press.

  18. Dunajska K, Milewicz A, Jedrzejuk D, et al.: Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men. Endocrine 2004, 25:215–221.

    Article  PubMed  CAS  Google Scholar 

  19. Yamauchi T, Kamon J, Waki H, et al.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941–946.

    Article  PubMed  CAS  Google Scholar 

  20. Arita Y, Kihara S, Ouchi N, et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79–83.

    Article  PubMed  CAS  Google Scholar 

  21. Ouchi N, Kihara S, Arita Y, et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473–2476.

    PubMed  CAS  Google Scholar 

  22. Shibata R, Ouchi N, Kihara S, et al.: Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 2004, 279:28670–28674.

    Article  PubMed  CAS  Google Scholar 

  23. Kern PA, Ranganathan S, Li C, et al.: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745–E751.

    PubMed  CAS  Google Scholar 

  24. Hotamisligil GS, Arner P, Caro JF, et al.: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95:2409–2415.

    Article  PubMed  CAS  Google Scholar 

  25. Moller DE: Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000, 11:212–217.

    Article  PubMed  CAS  Google Scholar 

  26. Avellone G, Avellone G, Di Garbo V, et al.: Evaluation of cardiovascular risk factors in overweight and obese subjects. Int Angiol 1994, 13:25–29.

    PubMed  CAS  Google Scholar 

  27. Mertens I, Van Gaal LF: Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med 2005, 5:48–55.

    Article  PubMed  Google Scholar 

  28. Palomo I, Alarcon M, Moore-Carrasco R, Argiles JM: Hemostasis alterations in metabolic syndrome (review). Int J Mol Med 2006, 18:969–974.

    PubMed  CAS  Google Scholar 

  29. Steppan CM, Lazar MA: The current biology of resistin. J Intern Med 2004, 255:439–447.

    Article  PubMed  CAS  Google Scholar 

  30. McTernan PG, Kusminski CM, Kumar S: Resistin. Curr Opin Lipidol 2006, 17:170–175.

    Article  PubMed  CAS  Google Scholar 

  31. Patel L, Buckels AC, Kinghorn IJ, et al.: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003, 300:472–476.

    Article  PubMed  CAS  Google Scholar 

  32. Shetty GK, Economides PA, Horton ES, et al.: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450–2457.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Room 525 D, Houston, TX, 77030, USA

    John A. Farmer MD

Authors
  1. Sachin Mehta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John A. Farmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John A. Farmer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehta, S., Farmer, J.A. Obesity and inflammation: A new look at an old problem. Curr Atheroscler Rep 9, 134–138 (2007). https://doi.org/10.1007/s11883-007-0009-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-007-0009-4

Keywords

Search

Navigation